As more people receive COVID-19 vaccines and boosters, some people with a compromised immune system or a history of bad reactions to vaccines may need alternate options.

Federal funding for COVID-19 testing and treatment of uninsured Americans has dried up as of two days ago. Health Services and Resources Administration also announced coverage for COVID-19 vaccines for the uninsured will no longer be available after April 5.

The European Union's drug regulator says it's recommending that an antibody drug developed by AstraZeneca be authorized to help people avoid getting sick with the coronavirus.

Two COVID-19 antiviral pills are available for free in the U.S., but getting them quickly can be challenging.

As more places drop mask orders and other COVID-19 precautions, there's new urgency in finding ways to protect up to 7 million Americans with severely weak immune systems.

U.S. officials have authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination.